Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2602-2609

  Paine III, Robert ^a,d   Preston, Angela M ^a   Wilcoxen, Steven ^a   Jin, Hong ^a   Siu, Brian B ^a   Morris, Susan B ^a   Reed, Jacquelyn A ^c   Ross, Gary ^c   Whitsett, Jeffrey A ^c   Beck, James M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HOST RESISTANCE; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034161743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2602     Document Type: Article

References (54)

1. Stansell, J. D., D. H. Osmond, E. Charlebois, L. LaVange, J. M. Wallace, B. V. Alexander, J. Glassroth, P. A. Kvale, M. J. Rosen, L. B. Reichman, et al. 1997. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons: Pulmonary Complications of HIV Infection Study Group. Am. J. Respir. Crit. Care Med 155:60.
2. Levine, S. J. 1996. Pneumocystis carinii. Clin. Chest Med. 17:665.
3. Phair, J., A. Muñoz, R. Detels, R. Kaslow, C. Rinaldo, A. Saah, and the Multicenter AIDS Cohort Study Group. 1990. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N. Engl. J. Med. 322:161.
4. Beck, J. M., M. L. Warnock, J. L. Curtis, M. J. Sniezek, S. M. Arraj-Peffer, H. B. Kaltreider, and J. E. Shellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186.
5. Yoneda, K., and P. D. Walzer. 1983. Attachment of Pneumocystis carinii to type 1 alveolar cells studied by freeze-fracture electron microscopy. Infect. Immun. 40:812.
6. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99:2110.
7. Ezekowitz, R. A., D. J. Williams, H. Koziel, M. Y. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155.
8. Kolls, J. K., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370.
9. Limper, A. H. 1997. Tumor necrosis factor α-mediated host defense against Pneumocystis carinii. Am. J. Respir. Cell Mol. Biol. 16:110.
10. Lipschik, G. Y., M. E. Doerfler, J. A. Kovacs, W. D. Travis, V. A. Andrawis, M. G. Lawrence, J. R. Dichter, F. P. Ognibene, and J. H. Shelhamer. 1993. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104:763.
11. Lipschik, G. Y., J. F. Treml, and S. D. Moore. 1996. Pneumocystis carinii glycoprotein A stimulates interleukin-8 production and inflammatory cell activation in alveolar macrophages and cultured monocytes. J. Eukaryotic Microbiol. 43: 16S.
12. Castro, M., T. I. Morgenthaler, O. A. Hoffman, J. E. Standing, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:73.
13. Limper, A. H., J. E. Standing, and J. S. Hoyte. 1996. The role of alveolar macrophages in Pneumocystis carinii elimination from the lower respiratory tract. J. Eukaryotic Microbiol 43:12S.
14. Gasson, J. C. 1991. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131.
15. Akagawa, K. S., K. Kamoshita, and T. Tokunaga. 1988. Effects of granulocyte-macrophage colony-stimulating factor and colony stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. J. Immunol. 141:3383.
16. Nakata, K., K. S. Akagawa, M. Fukayama, Y. Hayashi, M. Kadokura, and T. Tokunaga. 1991. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J. Immunol. 147:1266.
17. O'Brien, A. D., T. J. Standiford, P. J. Christensen, S. E. Wilcoxen, and R. Paine. 1998. Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells. J. Lab. Clin. Med. 131:417.
18. Chen, G. H., J. L. Curtis, C. H. Mody, P. J. Christensen, L. R. Armstrong, and G. B. Toews. 1994. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro, J. Immunol. 152: 724.
19. Reed, S. G., C. F. Nathan, D. L. Pihl, P. Rodricks, K. Shanebeck, P. J. Conlon, and K. H. Grabstein. 1987. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma crazi and release hydrogen peroxide: comparison with interferon γ J. Exp. Med. 166:1734.
20. LeVine, A. M., J. A. Reed, K. E. Kurak, E. Cianciolo, and I. A. Whitsett. 1999. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103:563.
21. Taylor, M. B., and C. S. Easmon. 1991. The neutrophil chemiluminescence response to Pneumocystis carinii is stimulated by GM-CSF and γ interferon. FEMS Microbiol. Immunol. 4:41.
22. Laursen, A. L., N. Obel, J. Rungby, and P. L. Andersen. 1993. Phagocytosis and stimulation of the respiratory burst in neutrophils by Pneumocystis carinii. J. Infect. Dis. 168:1466.
23. Egglelon, P., and K. B. Reid. 1999. Lung surfactant proteins involved in innate immunity. Curr. Opin. Immunol. 11:28.
24. Limper, A. H., E. C. Crouch, O'Riordan, D. M., D. Chang, Z. Vuk-Pavlovic, J. E. Standing, K. Y. Kwon, and A. Adlakha. 1995. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J. Lab. Clin. Med. 126:416.
25. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699.
26. Williams, M. D., J. R. Wright, K. L. March, and W. J. Martin, II. 1996. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14:232.
27. Mandujano, J. F., D'Souza, N. B., S. Nelson, W. R. Summer, R. C. Beckerman, and J. E. Shellito. 1995. Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151: 1233.
28. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713.
29. Huffman, J. A., W. M. Hull, G. Dranoff, R. C. Mulligan, and J. A. Whitsett. 1996. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97:649.
30. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the mutine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
31. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J. Immunol. 161:360.
32. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128:477.
33. Ikegami, M., T. Ueda, W. Hull, J. A. Whitsett, R. C. Mulligan, G. Dranoff, and A. H. Jobe. 1996. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 270:1650.
34. Elhalwagi, B. M., M. Zhang, M. Ikegami, H. S. Iwamoto, R. E. Morris, M. L. Miller, K. Dienger, and F. X. McCormack. 1999. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am. J. Resp. Cell Mol. Biol. 21:380.
35. Ferguson, J. S., D. R. Voelker, F. X. McCormack, and L. S. Schlesinger. 1999. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol. 163:312.
36. Kaneshiro, E. S., M. A. Wyder, L. H. Zhou, J. E. Ellis, D. R. Voelker, and S. G. Langreth. 1993, Characterization of Pneumocystis carinii preparations developed for lipid analysis. J. Eukaryotic Microbiol. 40:805.
37. Koziel, H., D. S. Phelps, J. A. Fishman, M. Y. Armstrong, F. F. Richards, and R. M. Rose. 1998. Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro. Am. J. Respir. Cell Mol. Biol. 18:834.
38. Zar, J. H. 1984. Biostatistical Analysis, 2nd ed. Prentice-Hall, Englewood Cliffs.
39. Beck, J. M., M. J. Sniezek, S. M. Arraj-Peffer, J. L. Curtis, and J. E. Shellito. 1990. Cellular responses to Pneumocystis carinii in a murine model. Am. Rev. Respir. Dis. 141:A530.
40. Huffman Reed, J. A., W. R. Rice, Z. K. Zsengeller, S. E. Wert, G. Dranoff, and J. A. Whitsett. 1997. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am. J. Physiol. 273:L715.
41. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor α and γ Interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279.
42. Kolls, J. K., D. Lei, C. Vazquez, G. Odom, W. R. Summer, S. Nelson, and J. Shellito. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-tnediated gene transfer of a TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112.
43. Crouch, E. C. 1998. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 19:177.
44. Wright, J. R. 1997. Immunomodulatory functions of surfactant. Physiol. Rev. 77:931.
45. Ikegami, M., A. H. Jobe, J. A. Huffman Reed, and J. A. Whitsett. 1997. Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice. Am. J. Physiol 273:1709.
46. Harris, C. E., M. Linke, P. Walzer, M. Bruno, J. Whitsett, and T. Korfhagen. 1998. Increased P. carinii infection in lungs of SP-A deficient mice. Am. J. Resp. Crit. Care Med. 157:A236.
47. Braunstein, S., G. Kaplan, A. B. Gottlieb, M. Schwartz, G. Walsh, R. M. Abalos, T. T. Fajardo, L. S. Guido, and J. G. Krueger. 1994. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Dermatol. 103:601.
48. 2. Exp. Mol. Pathol. 22:142.
49. Gigliotti, F. 1992. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 165:329.
50. Furuta, T., and K. Ueda. 1987. Intra- and inter-species transmission and antigenic difference of Pneumocystis carinii derived from rat and mouse. Jpn. J. Exp. Med. 57:11.
51. Reed, J. A., and J. A. Whitsett. 1998. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis. Proc. Assoc. Am. Physicians 110:321.
52. Crowe, S. M., and A. Lopez. 1997. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage. J. Leukocyte Biol. 62:41.
53. Reed, J. A., M. Ikeegami, E. R. Cianciolo, W. Lu, P. S. Cho, W. Hull, A. H. Jobe, and J. A. Whitsett. 1999. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am. J. Physiol. 276:L556.
54. Zsengeller, Z. K., J. A. Reed, C. J. Bachurski, A. M. LeVine, S. Forry-Schaudies, R. Hirsch, and J. A. Whilsett. 1998. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. Hum. Gene Ther. 9:2101.